HA
CL icon

Hamel Associates’s Colgate-Palmolive CL Stock Holding History

Hamel Associates’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$430K Hold
4,690
– – 0.12% 72
2026
Q1 		$400K Buy
4,690
+575
+14% +$51.2K 0.11% 69
2025
Q4 		$325K Buy
+4,115
New +$323K 0.1% 69
2023
Q3 		– Sell
-4,365
Closed -$336K – 75
2023
Q2 		$336K Sell
4,365
-750
-15% -$58.1K 0.12% 67
2023
Q1 		$385K Hold
5,115
– – 0.13% 72
2022
Q4 		$403K Sell
5,115
-6,000
-54% -$450K 0.14% 71
2022
Q3 		$781K Hold
11,115
– – 0.31% 59
2022
Q2 		$891K Sell
11,115
-4,500
-29% -$352K 0.35% 56
2022
Q1 		$1.18M Hold
15,615
– – 0.42% 50
2021
Q4 		$1.33M Hold
15,615
– – 0.48% 50
2021
Q3 		$1.18M Hold
15,615
– – 0.46% 49
2021
Q2 		$1.27M Buy
15,615
+25
+0.2% +$2.04K 0.48% 49
2021
Q1 		$1.23M Sell
15,590
-525
-3% -$41.1K 0.47% 49
2020
Q4 		$1.38M Buy
16,115
+340
+2% +$28.1K 0.56% 45
2020
Q3 		$1.22M Buy
15,775
+850
+6% +$64.8K 0.54% 44
2020
Q2 		$1.09M Hold
14,925
– – 0.53% 42
2020
Q1 		$990K Buy
14,925
+600
+4% +$42.3K 0.52% 41
2019
Q4 		$986K Sell
14,325
-550
-4% -$37.5K 0.41% 52
2019
Q3 		$1.09M Hold
14,875
– – 0.47% 51
2019
Q2 		$1.07M Sell
14,875
-3,050
-17% -$217K 0.47% 49
2019
Q1 		$1.23M Sell
17,925
-5,100
-22% -$329K 0.55% 50
2018
Q4 		$1.37M Sell
23,025
-450
-2% -$28.2K 0.68% 45
2018
Q3 		$1.57M Sell
23,475
-10,805
-32% -$720K 0.68% 51
2018
Q2 		$2.22M Sell
34,280
-9,275
-21% -$607K 1.02% 33
2018
Q1 		$3.12K Sell
43,555
-10,475
-19% -$754K 0.21% 24
2017
Q4 		$4.08M Sell
54,030
-650
-1% -$47.5K 1.93% 20
2017
Q3 		$3.98M Hold
54,680
– – 1.94% 19
2017
Q2 		$4.05M Buy
54,680
+550
+1% +$40.8K 2.04% 20
2017
Q1 		$3.96M Buy
54,130
+32,475
+150% +$2.27M 2.02% 21
2016
Q4 		$1.42M Sell
21,655
-30
-0.1% -$2.06K 0.73% 40
2016
Q3 		$1.61M Sell
21,685
-445
-2% -$32.9K 0.85% 39
2016
Q2 		$1.62M Hold
22,130
– – 0.84% 41
2016
Q1 		$1.56M Hold
22,130
– – 0.83% 40
2015
Q4 		$1.47M Buy
22,130
+1,250
+6% +$83.2K 0.94% 36
2015
Q3 		$1.32M Sell
20,880
-2,175
-9% -$142K 0.94% 36
2015
Q2 		$1.32M Sell
23,055
-800
-3% -$54.3K 0.87% 43
2015
Q1 		$1.66M Sell
23,855
-650
-3% -$44.9K 1.09% 37
2014
Q4 		$1.7M Sell
24,505
-225
-0.9% -$15.2K 1.1% 37
2014
Q3 		$1.61M Sell
24,730
-150
-0.6% -$9.89K 1.08% 35
2014
Q2 		$1.7M Buy
24,880
+3,500
+16% +$235K 1.12% 33
2014
Q1 		$1.61M Sell
21,380
-3,500
-14% -$221K 1.12% 34
2013
Q4 		$1.62M Buy
+24,880
New +$1.59M 1.14% 34

Other funds holding CL

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM

Hamel Associates's CL Position: Q2 2026 in Review

Hamel Associates held its Colgate-Palmolive (CL) position steady in Q2 2026 at 4,690 shares worth $430K. The position accounts for 0.12% of the portfolio, ranked #72.

Hamel Associates first reported a position in CL in Q4 2013 and has held it in 42 quarters since. The position peaked at $4.08M in Q4 2017. 895 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Hamel Associates held 4,690 shares of Colgate-Palmolive worth $430K as of Q2 2026.
  • Hamel Associates left its Colgate-Palmolive share count unchanged in Q2 2026.
  • Colgate-Palmolive made up 0.12% of Hamel Associates's portfolio in Q2 2026, its #72 holding.
  • Hamel Associates first reported a position in Colgate-Palmolive in Q4 2013 and has held it in 42 quarters since.
  • Hamel Associates's Colgate-Palmolive position peaked at $4.08M in Q4 2017.
  • 895 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Hamel Associates's 13F filing for Q2 2026, filed 27 Jul 2026.